Global and United States Bromhexine Market Insights, Forecast to 2026

Publisher Name :
Date: 25-Sep-2020
No. of pages: 148
Inquire Before Buying

Bromhexine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bromhexine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Bromhexine market is segmented into

- Oral

- Injection

Segment by Application, the Bromhexine market is segmented into

- Chronic Bronchitis

- Asthma

- Other

Regional and Country-level Analysis

The Bromhexine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Bromhexine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Bromhexine Market Share Analysis

Bromhexine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bromhexine business, the date to enter into the Bromhexine market, Bromhexine product introduction, recent developments, etc.

The major vendors covered:

- Sanofi Aventis

- Teva

- Boehringer Ingelheim

- Novartis

- Mylan

- Sanyo Chemical Laboratroy

- Sandoz

- LGM Pharma

- GSK

- Mayne Pharma

- Sigma-Aldrich

- Abbott

- Shanghai Sine Tianping Pharmaceutical

- Takeda

- Shanghai Xudong Haipu Pharmaceutical

- Jincheng Haisi Pharmaceutical

- Shanxi Powerdone Pharmaceutical

- Shanxi Powerdone Pharmaceutical

- Wanbangde Pharmaceutical Group

- Shijiazhuang No.4 Pharmaceutical

- Ma'AnShan BBCA Pharmaceutical

Global and United States Bromhexine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Bromhexine Product Introduction
1.2 Market Segments
1.3 Key Bromhexine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bromhexine Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Bromhexine Market Size Growth Rate by Application
1.5.2 Chronic Bronchitis
1.5.3 Asthma
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bromhexine Market Size, Estimates and Forecasts
2.1.1 Global Bromhexine Revenue 2015-2026
2.1.2 Global Bromhexine Sales 2015-2026
2.2 Global Bromhexine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Bromhexine Historical Market Size by Region (2015-2020)
2.3.1 Global Bromhexine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Bromhexine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Bromhexine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Bromhexine Sales Forecast by Region (2021-2026)
2.4.2 Global Bromhexine Revenue Forecast by Region (2021-2026)
3 Global Bromhexine Competitor Landscape by Players
3.1 Global Top Bromhexine Sales by Manufacturers
3.1.1 Global Bromhexine Sales by Manufacturers (2015-2020)
3.1.2 Global Bromhexine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Bromhexine Manufacturers by Revenue
3.2.1 Global Bromhexine Revenue by Manufacturers (2015-2020)
3.2.2 Global Bromhexine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bromhexine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bromhexine Revenue in 2019
3.2.5 Global Bromhexine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Bromhexine Price by Manufacturers
3.4 Global Bromhexine Manufacturing Base Distribution, Product Types
3.4.1 Bromhexine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bromhexine Product Type
3.4.3 Date of International Manufacturers Enter into Bromhexine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bromhexine Market Size by Type (2015-2020)
4.1.1 Global Bromhexine Sales by Type (2015-2020)
4.1.2 Global Bromhexine Revenue by Type (2015-2020)
4.1.3 Bromhexine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bromhexine Market Size Forecast by Type (2021-2026)
4.2.1 Global Bromhexine Sales Forecast by Type (2021-2026)
4.2.2 Global Bromhexine Revenue Forecast by Type (2021-2026)
4.2.3 Bromhexine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bromhexine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bromhexine Market Size by Application (2015-2020)
5.1.1 Global Bromhexine Sales by Application (2015-2020)
5.1.2 Global Bromhexine Revenue by Application (2015-2020)
5.1.3 Bromhexine Price by Application (2015-2020)
5.2 Bromhexine Market Size Forecast by Application (2021-2026)
5.2.1 Global Bromhexine Sales Forecast by Application (2021-2026)
5.2.2 Global Bromhexine Revenue Forecast by Application (2021-2026)
5.2.3 Global Bromhexine Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Bromhexine Market Size YoY Growth 2015-2026
6.1.1 United States Bromhexine Sales YoY Growth 2015-2026
6.1.2 United States Bromhexine Revenue YoY Growth 2015-2026
6.1.3 United States Bromhexine Market Share in Global Market 2015-2026
6.2 United States Bromhexine Market Size by Players (International and Local Players)
6.2.1 United States Top Bromhexine Players by Sales (2015-2020)
6.2.2 United States Top Bromhexine Players by Revenue (2015-2020)
6.3 United States Bromhexine Historic Market Review by Type (2015-2020)
6.3.1 United States Bromhexine Sales Market Share by Type (2015-2020)
6.3.2 United States Bromhexine Revenue Market Share by Type (2015-2020)
6.3.3 United States Bromhexine Price by Type (2015-2020)
6.4 United States Bromhexine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Bromhexine Sales Forecast by Type (2021-2026)
6.4.2 United States Bromhexine Revenue Forecast by Type (2021-2026)
6.4.3 United States Bromhexine Price Forecast by Type (2021-2026)
6.5 United States Bromhexine Historic Market Review by Application (2015-2020)
6.5.1 United States Bromhexine Sales Market Share by Application (2015-2020)
6.5.2 United States Bromhexine Revenue Market Share by Application (2015-2020)
6.5.3 United States Bromhexine Price by Application (2015-2020)
6.6 United States Bromhexine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Bromhexine Sales Forecast by Application (2021-2026)
6.6.2 United States Bromhexine Revenue Forecast by Application (2021-2026)
6.6.3 United States Bromhexine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Bromhexine Market Size YoY Growth 2015-2026
7.2 North America Bromhexine Market Facts & Figures by Country
7.2.1 North America Bromhexine Sales by Country (2015-2020)
7.2.2 North America Bromhexine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Bromhexine Market Size YoY Growth 2015-2026
8.2 Europe Bromhexine Market Facts & Figures by Country
8.2.1 Europe Bromhexine Sales by Country
8.2.2 Europe Bromhexine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Bromhexine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Bromhexine Market Facts & Figures by Country
9.2.1 Asia Pacific Bromhexine Sales by Region (2015-2020)
9.2.2 Asia Pacific Bromhexine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Bromhexine Market Size YoY Growth 2015-2026
10.2 Latin America Bromhexine Market Facts & Figures by Country
10.2.1 Latin America Bromhexine Sales by Country
10.2.2 Latin America Bromhexine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Bromhexine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Bromhexine Market Facts & Figures by Country
11.2.1 Middle East and Africa Bromhexine Sales by Country
11.2.2 Middle East and Africa Bromhexine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Sanofi Aventis
12.1.1 Sanofi Aventis Corporation Information
12.1.2 Sanofi Aventis Description and Business Overview
12.1.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Aventis Bromhexine Products Offered
12.1.5 Sanofi Aventis Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Bromhexine Products Offered
12.2.5 Teva Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Bromhexine Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Bromhexine Products Offered
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Bromhexine Products Offered
12.5.5 Mylan Recent Development
12.6 Sanyo Chemical Laboratroy
12.6.1 Sanyo Chemical Laboratroy Corporation Information
12.6.2 Sanyo Chemical Laboratroy Description and Business Overview
12.6.3 Sanyo Chemical Laboratroy Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanyo Chemical Laboratroy Bromhexine Products Offered
12.6.5 Sanyo Chemical Laboratroy Recent Development
12.7 Sandoz
12.7.1 Sandoz Corporation Information
12.7.2 Sandoz Description and Business Overview
12.7.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sandoz Bromhexine Products Offered
12.7.5 Sandoz Recent Development
12.8 LGM Pharma
12.8.1 LGM Pharma Corporation Information
12.8.2 LGM Pharma Description and Business Overview
12.8.3 LGM Pharma Sales, Revenue and Gross Margin (2015-2020)
12.8.4 LGM Pharma Bromhexine Products Offered
12.8.5 LGM Pharma Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Description and Business Overview
12.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GSK Bromhexine Products Offered
12.9.5 GSK Recent Development
12.10 Mayne Pharma
12.10.1 Mayne Pharma Corporation Information
12.10.2 Mayne Pharma Description and Business Overview
12.10.3 Mayne Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mayne Pharma Bromhexine Products Offered
12.10.5 Mayne Pharma Recent Development
12.11 Sanofi Aventis
12.11.1 Sanofi Aventis Corporation Information
12.11.2 Sanofi Aventis Description and Business Overview
12.11.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sanofi Aventis Bromhexine Products Offered
12.11.5 Sanofi Aventis Recent Development
12.12 Abbott
12.12.1 Abbott Corporation Information
12.12.2 Abbott Description and Business Overview
12.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Abbott Products Offered
12.12.5 Abbott Recent Development
12.13 Shanghai Sine Tianping Pharmaceutical
12.13.1 Shanghai Sine Tianping Pharmaceutical Corporation Information
12.13.2 Shanghai Sine Tianping Pharmaceutical Description and Business Overview
12.13.3 Shanghai Sine Tianping Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Shanghai Sine Tianping Pharmaceutical Products Offered
12.13.5 Shanghai Sine Tianping Pharmaceutical Recent Development
12.14 Takeda
12.14.1 Takeda Corporation Information
12.14.2 Takeda Description and Business Overview
12.14.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Takeda Products Offered
12.14.5 Takeda Recent Development
12.15 Shanghai Xudong Haipu Pharmaceutical
12.15.1 Shanghai Xudong Haipu Pharmaceutical Corporation Information
12.15.2 Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
12.15.3 Shanghai Xudong Haipu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Shanghai Xudong Haipu Pharmaceutical Products Offered
12.15.5 Shanghai Xudong Haipu Pharmaceutical Recent Development
12.16 Jincheng Haisi Pharmaceutical
12.16.1 Jincheng Haisi Pharmaceutical Corporation Information
12.16.2 Jincheng Haisi Pharmaceutical Description and Business Overview
12.16.3 Jincheng Haisi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Jincheng Haisi Pharmaceutical Products Offered
12.16.5 Jincheng Haisi Pharmaceutical Recent Development
12.17 Shanxi Powerdone Pharmaceutical
12.17.1 Shanxi Powerdone Pharmaceutical Corporation Information
12.17.2 Shanxi Powerdone Pharmaceutical Description and Business Overview
12.17.3 Shanxi Powerdone Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Shanxi Powerdone Pharmaceutical Products Offered
12.17.5 Shanxi Powerdone Pharmaceutical Recent Development
12.18 Shanxi Powerdone Pharmaceutical
12.18.1 Shanxi Powerdone Pharmaceutical Corporation Information
12.18.2 Shanxi Powerdone Pharmaceutical Description and Business Overview
12.18.3 Shanxi Powerdone Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Shanxi Powerdone Pharmaceutical Products Offered
12.18.5 Shanxi Powerdone Pharmaceutical Recent Development
12.19 Wanbangde Pharmaceutical Group
12.19.1 Wanbangde Pharmaceutical Group Corporation Information
12.19.2 Wanbangde Pharmaceutical Group Description and Business Overview
12.19.3 Wanbangde Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Wanbangde Pharmaceutical Group Products Offered
12.19.5 Wanbangde Pharmaceutical Group Recent Development
12.20 Shijiazhuang No.4 Pharmaceutical
12.20.1 Shijiazhuang No.4 Pharmaceutical Corporation Information
12.20.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
12.20.3 Shijiazhuang No.4 Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Shijiazhuang No.4 Pharmaceutical Products Offered
12.20.5 Shijiazhuang No.4 Pharmaceutical Recent Development
12.21 Ma'AnShan BBCA Pharmaceutical
12.21.1 Ma'AnShan BBCA Pharmaceutical Corporation Information
12.21.2 Ma'AnShan BBCA Pharmaceutical Description and Business Overview
12.21.3 Ma'AnShan BBCA Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Ma'AnShan BBCA Pharmaceutical Products Offered
12.21.5 Ma'AnShan BBCA Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Bromhexine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bromhexine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Bromhexine Market Segments
Table 2. Ranking of Global Top Bromhexine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bromhexine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Bromhexine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Bromhexine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Bromhexine Sales by Regions 2015-2020 (K MT)
Table 9. Global Bromhexine Sales Market Share by Regions (2015-2020)
Table 10. Global Bromhexine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Bromhexine Sales Forecast by Region (2021-2026) (K MT)
Table 12. Global Bromhexine Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Bromhexine Sales Share by Manufacturers (2015-2020)
Table 14. Global Bromhexine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Bromhexine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bromhexine as of 2019)
Table 16. Bromhexine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Bromhexine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Bromhexine Price (2015-2020) (USD/MT)
Table 19. Bromhexine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Bromhexine Product Type
Table 21. Date of International Manufacturers Enter into Bromhexine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Bromhexine Sales by Type (2015-2020) (K MT)
Table 24. Global Bromhexine Sales Share by Type (2015-2020)
Table 25. Global Bromhexine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Bromhexine Revenue Share by Type (2015-2020)
Table 27. Bromhexine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Bromhexine Sales Share by Type (2021-2026)
Table 29. Global Bromhexine Sales by Application (2015-2020) (K MT)
Table 30. Global Bromhexine Sales Share by Application (2015-2020)
Table 31. Global Bromhexine Sales Share by Application (2021-2026)
Table 32. Global Bromhexine Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Bromhexine Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Bromhexine Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Bromhexine Sales (K MT) of Key Companies (2015-2020)
Table 36. United States Bromhexine Sales Share by Company (2015-2020)
Table 37. United States Bromhexine Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Bromhexine Sales (K MT) by Type (2015-2020)
Table 39. United States Bromhexine Sales Share by Type (2015-2020)
Table 40. United States Bromhexine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Bromhexine Price (K MT) by Type (2015-2020)
Table 42. United States Bromhexine Sales (K MT) by Type (2021-2026)
Table 43. United States Bromhexine Sales Share by Type (2021-2026)
Table 44. United States Bromhexine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Bromhexine Revenue Share by Type (2021-2026)
Table 46. United States Bromhexine Price (K MT) by Type (2021-2026)
Table 47. United States Bromhexine Sales (K MT) by Application (2015-2020)
Table 48. United States Bromhexine Sales Share by Application (2015-2020)
Table 49. United States Bromhexine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Bromhexine Sales (K MT) by Application (2021-2026)
Table 51. United States Bromhexine Sales Share by Application (2021-2026)
Table 52. United States Bromhexine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Bromhexine Revenue Share by Application (2021-2026)
Table 54. North America Bromhexine Sales by Country (2015-2020) (K MT)
Table 55. North America Bromhexine Sales Market Share by Country (2015-2020)
Table 56. North America Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Bromhexine Revenue Market Share by Country (2015-2020)
Table 58. Europe Bromhexine Sales by Country (2015-2020) (K MT)
Table 59. Europe Bromhexine Sales Market Share by Country (2015-2020)
Table 60. Europe Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Bromhexine Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Bromhexine Sales by Region (2015-2020) (K MT)
Table 63. Asia Pacific Bromhexine Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Bromhexine Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Bromhexine Revenue Market Share by Region (2015-2020)
Table 66. Latin America Bromhexine Sales by Country (2015-2020) (K MT)
Table 67. Latin America Bromhexine Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Bromhexine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Bromhexine Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Bromhexine Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Bromhexine Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Bromhexine Revenue Market Share by Country (2015-2020)
Table 74. Sanofi Aventis Corporation Information
Table 75. Sanofi Aventis Description and Business Overview
Table 76. Sanofi Aventis Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Sanofi Aventis Bromhexine Product
Table 78. Sanofi Aventis Recent Development
Table 79. Teva Corporation Information
Table 80. Teva Description and Business Overview
Table 81. Teva Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Teva Product
Table 83. Teva Recent Development
Table 84. Boehringer Ingelheim Corporation Information
Table 85. Boehringer Ingelheim Description and Business Overview
Table 86. Boehringer Ingelheim Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Boehringer Ingelheim Product
Table 88. Boehringer Ingelheim Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Business Overview
Table 91. Novartis Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Mylan Corporation Information
Table 95. Mylan Description and Business Overview
Table 96. Mylan Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Mylan Product
Table 98. Mylan Recent Development
Table 99. Sanyo Chemical Laboratroy Corporation Information
Table 100. Sanyo Chemical Laboratroy Description and Business Overview
Table 101. Sanyo Chemical Laboratroy Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Sanyo Chemical Laboratroy Product
Table 103. Sanyo Chemical Laboratroy Recent Development
Table 104. Sandoz Corporation Information
Table 105. Sandoz Description and Business Overview
Table 106. Sandoz Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Sandoz Product
Table 108. Sandoz Recent Development
Table 109. LGM Pharma Corporation Information
Table 110. LGM Pharma Description and Business Overview
Table 111. LGM Pharma Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. LGM Pharma Product
Table 113. LGM Pharma Recent Development
Table 114. GSK Corporation Information
Table 115. GSK Description and Business Overview
Table 116. GSK Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. GSK Product
Table 118. GSK Recent Development
Table 119. Mayne Pharma Corporation Information
Table 120. Mayne Pharma Description and Business Overview
Table 121. Mayne Pharma Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Mayne Pharma Product
Table 123. Mayne Pharma Recent Development
Table 124. Sigma-Aldrich Corporation Information
Table 125. Sigma-Aldrich Description and Business Overview
Table 126. Sigma-Aldrich Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Sigma-Aldrich Product
Table 128. Sigma-Aldrich Recent Development
Table 129. Abbott Corporation Information
Table 130. Abbott Description and Business Overview
Table 131. Abbott Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Abbott Product
Table 133. Abbott Recent Development
Table 134. Shanghai Sine Tianping Pharmaceutical Corporation Information
Table 135. Shanghai Sine Tianping Pharmaceutical Description and Business Overview
Table 136. Shanghai Sine Tianping Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Shanghai Sine Tianping Pharmaceutical Product
Table 138. Shanghai Sine Tianping Pharmaceutical Recent Development
Table 139. Takeda Corporation Information
Table 140. Takeda Description and Business Overview
Table 141. Takeda Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Takeda Product
Table 143. Takeda Recent Development
Table 144. Shanghai Xudong Haipu Pharmaceutical Corporation Information
Table 145. Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
Table 146. Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Shanghai Xudong Haipu Pharmaceutical Product
Table 148. Shanghai Xudong Haipu Pharmaceutical Recent Development
Table 149. Jincheng Haisi Pharmaceutical Corporation Information
Table 150. Jincheng Haisi Pharmaceutical Description and Business Overview
Table 151. Jincheng Haisi Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Jincheng Haisi Pharmaceutical Product
Table 153. Jincheng Haisi Pharmaceutical Recent Development
Table 154. Shanxi Powerdone Pharmaceutical Corporation Information
Table 155. Shanxi Powerdone Pharmaceutical Description and Business Overview
Table 156. Shanxi Powerdone Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Shanxi Powerdone Pharmaceutical Product
Table 158. Shanxi Powerdone Pharmaceutical Recent Development
Table 159. Shanxi Powerdone Pharmaceutical Corporation Information
Table 160. Shanxi Powerdone Pharmaceutical Description and Business Overview
Table 161. Shanxi Powerdone Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Shanxi Powerdone Pharmaceutical Product
Table 163. Shanxi Powerdone Pharmaceutical Recent Development
Table 164. Wanbangde Pharmaceutical Group Corporation Information
Table 165. Wanbangde Pharmaceutical Group Description and Business Overview
Table 166. Wanbangde Pharmaceutical Group Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Wanbangde Pharmaceutical Group Product
Table 168. Wanbangde Pharmaceutical Group Recent Development
Table 169. Shijiazhuang No.4 Pharmaceutical Corporation Information
Table 170. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
Table 171. Shijiazhuang No.4 Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Shijiazhuang No.4 Pharmaceutical Product
Table 173. Shijiazhuang No.4 Pharmaceutical Recent Development
Table 174. Ma'AnShan BBCA Pharmaceutical Corporation Information
Table 175. Ma'AnShan BBCA Pharmaceutical Description and Business Overview
Table 176. Ma'AnShan BBCA Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 177. Ma'AnShan BBCA Pharmaceutical Product
Table 178. Ma'AnShan BBCA Pharmaceutical Recent Development
Table 179. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 180. Key Challenges
Table 181. Market Risks
Table 182. Main Points Interviewed from Key Bromhexine Players
Table 183. Bromhexine Customers List
Table 184. Bromhexine Distributors List
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Bromhexine Product Picture
Figure 2. Global Bromhexine Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Bromhexine Sales Market Share by Application in 2020 & 2026
Figure 6. Chronic Bronchitis
Figure 7. Asthma
Figure 8. Other
Figure 9. Bromhexine Report Years Considered
Figure 10. Global Bromhexine Market Size 2015-2026 (US$ Million)
Figure 11. Global Bromhexine Sales 2015-2026 (K MT)
Figure 12. Global Bromhexine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Bromhexine Sales Market Share by Region (2015-2020)
Figure 14. Global Bromhexine Sales Market Share by Region in 2019
Figure 15. Global Bromhexine Revenue Market Share by Region (2015-2020)
Figure 16. Global Bromhexine Revenue Market Share by Region in 2019
Figure 17. Global Bromhexine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Bromhexine Revenue in 2019
Figure 19. Bromhexine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Bromhexine Sales Market Share by Type (2015-2020)
Figure 21. Global Bromhexine Sales Market Share by Type in 2019
Figure 22. Global Bromhexine Revenue Market Share by Type (2015-2020)
Figure 23. Global Bromhexine Revenue Market Share by Type in 2019
Figure 24. Global Bromhexine Market Share by Price Range (2015-2020)
Figure 25. Global Bromhexine Sales Market Share by Application (2015-2020)
Figure 26. Global Bromhexine Sales Market Share by Application in 2019
Figure 27. Global Bromhexine Revenue Market Share by Application (2015-2020)
Figure 28. Global Bromhexine Revenue Market Share by Application in 2019
Figure 29. United States Bromhexine Sales Growth Rate 2015-2026 (K MT)
Figure 30. United States Bromhexine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Bromhexine Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Bromhexine Players Market Share by Revenue in Bromhexine in 2019
Figure 33. United States Bromhexine Revenue Share by Type (2015-2020)
Figure 34. United States Bromhexine Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Bromhexine Revenue Share by Application (2015-2020)
Figure 36. United States Bromhexine Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 38. North America Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Bromhexine Sales Market Share by Country in 2019
Figure 40. North America Bromhexine Revenue Market Share by Country in 2019
Figure 41. U.S. Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 42. U.S. Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 44. Canada Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Bromhexine Sales Market Share by Country in 2019
Figure 48. Europe Bromhexine Revenue Market Share by Country in 2019
Figure 49. Germany Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Bromhexine Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Bromhexine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Bromhexine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Bromhexine Revenue Market Share by Region in 2019
Figure 63. China Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Bromhexine Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Bromhexine Revenue Growth Rate (2015-2020) (US$ Million)
Figu
  • Global Carbocisteine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Carbocisteine market size was valued at US$ 55 million in 2023. With growing demand in downstream market, the Carbocisteine is forecast to a readjusted size of US$ 76 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Carbocisteine market. Carbocisteine are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Bovine Respiratory Disease Treatment Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for......
  • Global Ambroxol Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 91
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ambroxol market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva - Bayer - Novartis - Mylan - Bidachem - Hanmi - Hexal Pharma - Sris Pharmaceuticals - Hubei Ocean Biotechnology - DM Pharma......
  • Global Carbocisteine Professional Survey Report 2023, Forecast to 2028
    Published: 23-Nov-2023        Price: US 3280 Onwards        Pages: 101
    Carbocisteine is a type of medicine called a mucolytic. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to de......
  • Global Carbocisteine Market Research Report 2023, Forecast to 2028
    Published: 23-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Carbocisteine is a type of medicine called a mucolytic. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to de......
  • Global Bovine Respiratory Disease Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Bovine Respiratory Disease Treatment market: According to our latest research, the global Bovine Respiratory Disease Treatment market looks promising in the next 5 years. As of 2022, the global Bovine Respiratory Disease Treatment market was estimated at USD 1748.69 million, and it's anticipated to reach USD 2423.79 million in 2028, with a CAGR of 5.59% during the forecast years. Bovine respiratory disease (BRD) is a multifactorial and complex diseas......
  • Respiratory Collaboration and Licensing Deals 2016-2023
    Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 200
    Respiratory Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the respiratory deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of respiratory deals from 2016 to 2023. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Understanding......
  • Global Drugs For Respiratory Syncytial Virus (Rsv) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Sep-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Drugs For Respiratory Syncytial Virus (Rsv) market: According to our latest research, the global Drugs For Respiratory Syncytial Virus (Rsv) market looks promising in the next 5 years. As of 2022, the global Drugs For Respiratory Syncytial Virus (Rsv) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and......
  • Global Ambroxol Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Sep-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Ambroxol market: According to our latest research, the global Ambroxol market looks promising in the next 5 years. As of 2022, the global Ambroxol market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Ambroxol market, with a systematical descriptio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs